Harvoni


Film-coated tablets
scheduling status
S4
registration number
51/20.2.8/0369
What Harvoni contains
90 mg Ledipasvir and 400 mg Sofosbuvir.
other ingredients
Copovidone Microcrystalline cellulose (E460(i)) Croscarmellose sodium Colloidal silicon dioxide Magnesium stearate (E470b) Polyvinyl alcohol (E1203) Titanium dioxide (E171) Macrogol (Polyethylene glycol) 3350 (E1521) Talc (E553b) 165 mg lactose per tablet.
Therapeutic classification
J05AP51 Direct-acting antiviral.
© 2026 SAHPRA. ALL RIGHTS RESERVED